Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Denis

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Epilepsia|February 16, 2026
Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticusAurélie Hanin, Clémence Marois, Martin Guillemaud, et al.
European Journal of Clinical Investigation|September 23, 2015
Research update for articles published in EJCI in 2013Rosanna Abbate, Nasser M Al-Daghri, Paolo Andreozzi, et al.
Nature Medicine|August 9, 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Epilepsia|February 16, 2026
Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticusAurélie Hanin, Clémence Marois, Martin Guillemaud, et al.
European Journal of Clinical Investigation|September 23, 2015
Research update for articles published in EJCI in 2013Rosanna Abbate, Nasser M Al-Daghri, Paolo Andreozzi, et al.
Nature Medicine|August 9, 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Pageof 20